2.8501.04% ( -0.030 )
延迟 已收盘: 11月20日 16:08:00股东
全部股东
股东类型
- 公众及其他63.74%
- 个人与内部人士16.41%
- 员工持股计划10.60%
- 风投/私募8.47%
- 机构投资者0.78%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
Wenzhi TianFounder, CEO, Chief Scientific Officer & Chairman of the Board | 16.41% | 7,048.30 万 | 0.00% | +0 | |
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP | 10.60% | 4,552.43 万 | 0.04% | -17.68 万 | |
Shanghai Yongkan Investment Management Co., Ltd. | 8.47% | 3,639.23 万 | 0.01% | +0 | |
GF Fund Management Co., Ltd. | 0.76% | 327.72 万 | <0.01% | +0 | |
Fullgoal Fund Management Co. Ltd. | 0.02% | 8.86 万 | <0.01% | +0 | |
Dimensional Fund Advisors LP | 0.00% | 0.00 | <0.01% | -1.88 万 | |
State Street Investment Management | 0.00% | 0.00 | 0.19% | -81.16 万 |
